Top Story

New trial will assess dabigatran for prevention of recurrent stroke

December 21, 2014

The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke of undetermined source, according to a press release from Boehringer Ingelheim.

The randomized, double blind, placebo-controlled trial will compare dabigatran (Pradaxa, Boehringer Ingelheim) 110 mg or 150 mg twice daily vs. acetylsalicylic acid 100 mg once daily.

CVD care improved across US hospitals from 2009 to 2013

December 20, 2014
The quality of care for patients with MI, HF, stroke and venous thromboembolism has improved across hospitals in the United States in recent years, according to an…
In the Journals

Stressful duties increased sudden cardiac death risk for police officers

December 19, 2014
Police officers engaged in stressful law enforcement duties such as suspect pursuits or rescue operations had a greater risk for sudden cardiac death compared with…
In the Journals

PCI process measures may not correlate with 30-day mortality

December 19, 2014
CHICAGO — Hospital performance measures for PCI processes failed to demonstrate an association with 30-day risk-standardized mortality rates, according to report…
Meeting News Coverage

Study results show no clear link between calcium channel blockers, breast cancer

December 19, 2014
CHICAGO — Analysis of a potential link between use of calcium channel blockers and risk for breast cancer yielded conflicting results in two separate cohorts…
More News Headlines »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
Meeting News Coverage Video
Healio AHA2014 Bhatt1 th

VIDEO: Deepak L. Bhatt, MD, MPH, discusses 'practice-changing' IMPROVE-IT results

December 14, 2014
CHICAGO — The "practice-changing" results from the IMPROVE-IT trial presented at the American Heart Association…
More »
CME
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »